Nasal glucagon treatment is under review by the FDA; if approved, doctors say it will be a simpler way to treat a dangerous condition.
September 26, 2018
Nasal glucagon treatment is under review by the FDA. If approved, doctors say it will be a faster, simpler way to treat hypoglycemia—a dangers condition caused by low blood sugar. Learn more.